Skip to main content

Table 1 Baseline patient characteristics

From: Correlations between disease-specific and generic health status questionnaires in patients with advanced COPD: a one-year observational study

 

Total sample (n = 105)

Study completed (n = 86)

Dropout (n = 19)

p-valuec

Male, n (%)

65 (61.9)

54 (62.8)

11 (57.9)

0.69

Age, years

66.3 (9.2)

65.7 (9.3)

68.8 (8.2)

0.18

BMI, kg/m2 d

26.3 (6.7)

26.5 (6.9)

25.5 (5.4)

0.99

Current smokers, n (%)

26 (24.8)

23 (26.7)

3 (15.8)

0.69

FEV1,% predictedd

34.1 (13.5)a

34.4 (13.6)b

32.7 (13.1)

0.60

Charlson index, points

2.5 (1.7)

2.4 (1.7)

2.7 (1.7)

0.50

Long-term oxygen therapy, n (%)

62 (59.0)

53 (61.6)

9 (47.4)

0.26

Borg scale (dyspnea), points

4.8 (2.0)

4.8 (2.0)

4.9 (2.1)

0.79

Borg scale (fatigue), points

4.6 (2.5)

4.4 (2.4)

5.3 (2.8)

0.15

HADS-A score, points

5.9 (4.5)

5.5 (4.2)

7.5 (5.6)

0.16

HADS-D score, points

6.3 (4.0)

6.0 (4.0)

7.7 (3.4)

0.10

Self-perceived mobility problems, n (%)

89 (84.8)

72 (83.8)

17 (89.5)

0.33

Dependent in personal care, n (%)

47 (44.8)

33 (38.4)

14 (73.6)

0.009

  1. Values expressed as mean (standard deviation [SD]), number of patients (n), proportion (%).
  2. Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in the first second; HADS-A, Hospital Anxiety and Depression Scale, Anxiety subscale; HADS-D, Hospital Anxiety and Depression Scale, Depression subscale. a n = 102; b n = 83; c comparison between patients who completed the study and patients who withdrew from the study; d non parametric statistic tests were used because of skewed data.